State v. Muraida

CourtNew Mexico Court of Appeals
DecidedAugust 8, 2013
Docket31,646
StatusPublished

This text of State v. Muraida (State v. Muraida) is published on Counsel Stack Legal Research, covering New Mexico Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
State v. Muraida, (N.M. Ct. App. 2013).

Opinion

IN THE COURT OF APPEALS OF THE STATE OF NEW MEXICO

Opinion Number: ________________

Filing Date: August 8, 2013

Docket No. 31,646

STATE OF NEW MEXICO,

Plaintiff-Appellant,

v.

GERARD MURAIDA,

Defendant-Appellee.

APPEAL FROM THE DISTRICT COURT OF BERNALILLO COUNTY Charles W. Brown, District Judge

Gary K. King, Attorney General Rebecca Salwin, Assistant Attorney General Santa Fe, NM

for Appellant

Stelzner, Winter, Warburton, Flores, Sanchez & Dawes, P.A. Luis G. Stelzner Sara N. Sanchez Albuquerque, NM

for Appellee

OPINION

HANISEE, Judge.

{1} The State appeals the district court’s dismissal of the criminal complaint charging Defendant Gerard Muraida, M.D., with abuse and/or neglect of a nursing home resident, who died due to blood loss from an excessively prescribed quantity of the anticoagulant drug Coumadin. The State argues that the district court impermissibly decided the merits of the case by implicitly engaging in fact finding in its dismissal of the complaint pursuant to Defendant’s pretrial Foulenfont motion. See State v. Foulenfont, 1995-NMCA-028, ¶ 2, 119

1 N.M. 788, 895 P.2d 1329 (allowing the dismissal of criminal charges on purely legal grounds when the district court assumes the factual predicate underlying the charges to be true). Because the complaint stated facts that if proven are sufficient to convict Defendant of abuse and/or neglect, we reverse.

I. FACTUAL ALLEGATIONS AND PROCEDURAL HISTORY

{2} The State’s complaint incorporates a sworn declaration (the report) by elder care specialist Loren G. Lipson, M.D., regarding the circumstances of the resident’s (identified herein as D.A.) medical care and death and alleges the facts we recite herein, which we must assume to be true. D.A., then eighty-four years old, suffered a heart attack and subsequently received acute care at the Heart Hospital of New Mexico in Albuquerque from August 2 to August 15, 2005. On August 15, D.A. was transferred to Albuquerque Care Center (ACC) for rehabilitation, where Defendant became her attending physician. Defendant saw D.A. once on August 16. As part of the treatment for D.A.’s heart attack, Defendant prescribed Coumadin, which D.A. had already begun to receive while being treated at the Heart Hospital of New Mexico. Coumadin is “an anti[]coagulant used to thin blood so it can more easily pass through constricted blood vessels.”

{3} Initially, Defendant utilized a blood test called Protime to monitor the anticoagulative effects of Coumadin on D.A. This test measures an individual’s clotting time (called the INR) in comparison with the standard clotting time for the average person, for which a baseline INR value of 1.0 is assigned. In this case, the therapeutic INR goal for D.A. was between 2.0 and 3.0. The complaint asserts that this test was an important tool for Defendant to evaluate and monitor D.A.’s coagulation because “Coumadin is a potentially dangerous drug and can result in excessive bleeding due to decreased clotting.” At the admission examination conducted by Defendant on August 16, Defendant noted that D.A. had “multiple bruises[,] ‘areas related to her anti[]coagulation and hospitalization.’ He also noted an elevated INR of ‘3.4’ which was higher th[an her therapeutic] ‘INR’ goal of ‘2 to 3.’ [At that time, D.A.’s] Coumadin dose was 1.0 mg per day.” Several days later on August 19, D.A.’s “INR was 1.74, [and Defendant] increased the Coumadin dose on [August 20] to 1.5 mg per day. Inexplicably, no additional INR’s were ordered for (a week) even though a new dose of Coumadin was started, and [D.A.’s] INR was elevated above the desired range [at the time of her] admission.” In his report, Dr. Lipson explained that “[w]hen the Coumadin dose is increased or decreased[,] the INR must be measured daily until a relative steady state is obtained. If too much Coumadin is given, any wound, vessel abnormality[,] or lesion where there may be a tendency to bleed has a greater chance of bleeding.”

{4} Also pursuant to Dr. Lipson’s report, the complaint maintains that “Dr. Muraida did not set blood pressure notification parameters, and actually ignored her low blood pressure when he examined her.” Notably, “low blood pressure [can be a sign of] acute bleeding and . . . dehydration.” Defendant also “failed to reduce [D.A.’s] blood pressure medication dosages or check her hydration status or hematologic status—all placing her at risk for further heart damage, stroke or other vital organ ischemic damage.”

2 {5} Six days following the increase in Coumadin dosage and upon discovery of blood in D.A.’s stool on August 26, Defendant “ordered [ACC] nursing to schedule a colonoscopy with a gastroenterologist . . . ‘for possible hemorrhoids’ ([without a] basis in [her] chart for that diagnosis). [In addition, t]he appointment was not asked for on an emergent basis.” No INR test was administered at that time. Dr. Lipson explained that the “[s]tandard of care . . . demanded an immediate evaluation of her gastrointestinal bleeding in a hospital, discontinuation of the Coumadin for at least two days[,] and daily measurement of her INR. Any gastrointestinal bleeding would place [D.A.] at risk for further heart damage from anemia and hypoxia.”

{6} The report also stated that Defendant was informed that D.A. had a nose bleed, knee swelling, and bright red blood in her stools after she suffered falls getting out of bed, yet Defendant did not properly address those issues. Ultimately, on September 1, D.A. was sent to the emergency room for acute rectal bleeding. The affidavit states that she was “massively over anticoagulated,” possessing an INR “greater than 12.5[,] despite her anticoagulation goal being [an INR of 2.0 to 3.0].” The complaint alleges that D.A. died from blood loss from a tumor in her colon as a result of the anticoagulation treatment. Dr. Lipson stated that “[h]ad [Defendant] on [August 26] immediately and aggressively followed up on her initial reported rectal bleeding by stopping the Coumadin and getting an emergent colon[o]scopy [, D.A.] would not have died on [September 1, 2005].” Dr. Lipson concluded that Defendant’s “grossly negligent conduct directly led to [D.A.’s] death.”

{7} Defendant’s pretrial Foulenfont motion, filed prior to any determination of probable cause by either a grand jury or a judge at a preliminary hearing, asserted that the charges against him should be immediately dismissed because the complaint and supporting affidavit did not allege facts sufficient to support a conviction for abuse and neglect of D.A. The State responded that ample facts were alleged in the complaint and supporting documents to establish Defendant’s criminal liability. The State also maintained that to the extent Defendant’s motion required inquiry into the facts, such questions should be resolved at trial. The district court granted the motion and dismissed all charges against Defendant, determining that “the undisputed facts cannot, as a matter of law, sustain the elements of the criminal offenses charged.” The State appeals, arguing that the district court wrongly decided the merits of the case before trial.

II. DISCUSSION

{8} Defendant was charged in a two-count criminal complaint with violating the Resident Abuse and Neglect Act (the Act). See NMSA 1978, §§ 30-47-1 to -10 (1990, as amended through 2010). Both counts alternatively alleged abuse and neglect under the Act. Count one was premised on injuries suffered by D.A.; count two was premised on her death.

{9} The Act provides criminal penalties for medical care administered in a residential setting that falls beneath legislated standards of acceptability.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

State v. Webb
2013 NMCA 27 (New Mexico Court of Appeals, 2012)
State v. Chavez
2009 NMSC 035 (New Mexico Supreme Court, 2009)
State v. Largo
2012 NMSC 015 (New Mexico Supreme Court, 2012)
State v. LaPIETRA
2010 NMCA 009 (New Mexico Court of Appeals, 2009)
State v. Greenwood
2012 NMCA 17 (New Mexico Court of Appeals, 2011)
State v. Archuleta
482 P.2d 242 (New Mexico Court of Appeals, 1970)
Santillanes v. State
849 P.2d 358 (New Mexico Supreme Court, 1993)
State v. Foulenfont
895 P.2d 1329 (New Mexico Court of Appeals, 1995)
State v. Yarborough
1996 NMSC 068 (New Mexico Supreme Court, 1996)
State v. Wasson
1998 NMCA 087 (New Mexico Court of Appeals, 1998)
State v. Bybee
781 P.2d 316 (New Mexico Court of Appeals, 1989)
State v. Schoonmaker
2008 NMSC 010 (New Mexico Supreme Court, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
State v. Muraida, Counsel Stack Legal Research, https://law.counselstack.com/opinion/state-v-muraida-nmctapp-2013.